Zynex Announces New In-Network Provider Status with Humana

Rhea-AI Summary

Zynex (ZYXIQ) announced a new in-network provider agreement with Humana (HUM), effective February 1, 2026.

The agreement brings Zynex electrotherapy products, including NexWave™, into Humana Medicare-PPO, POS, PFFS, HMO and multiple state Medicaid plans, expanding patient access nationwide; terms were not disclosed.

Key Figures

Humana members served: nearly 20 million people Effective date: February 1, 2026

2 metrics

Humana members served nearly 20 million people Humana membership across all fifty states

Effective date February 1, 2026 Start of Zynex in-network provider agreement with Humana

Market Reality Check

Price: $193.02 Vol: Volume 2,520,709 vs 20-da...

normal vol

$193.02 Last Close

Volume Volume 2,520,709 vs 20-day average 2,227,310 (relative volume 1.13) indicates interest above recent norms. normal

Technical Despite the move, shares at 193.02 remain below the 200-day MA of 256.46 and well under the 52-week high of 315.35.

Peers on Argus

Humana is up 3.11% while key peers are mixed: ELV (-0.57%), CNC (-0.51%), MOH (-...

1 Up

Humana is up 3.11% while key peers are mixed: ELV (-0.57%), CNC (-0.51%), MOH (-0.05%) down, CI (+1.34%) and CVS (+1.82%) up. Momentum scans only flag GEHC up 5.56% without news, suggesting this move is more company-specific than a broad healthcare plans rally.

Historical Context

5 past events · Latest: Jan 26 (Positive)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Jan 26	Scholarship initiative	Positive	-1.1%	$3M scholarship fund to expand physician workforce in Louisiana.
Jan 13	Oncology partnership	Positive	-0.9%	Partnership with Atlas Oncology to expand coordinated cancer care.
Jan 12	Pharmacy program	Positive	-0.1%	CenterWell Pharmacy to dispense obesity drugs in employer program.
Jan 09	Earnings scheduling	Neutral	-0.3%	Announcement of Q4 2025 results release and earnings call timing.
Dec 17	Nursing mentorship	Positive	+0.8%	Partnership to fund Mentoring for Success program for nursing students.

Pattern Detected

Recent strategic and partnership announcements have often seen flat-to-negative next-day reactions, even when qualitatively positive.

Recent Company History

Over the past few months, Humana has focused on partnerships and community investment, including a $3 million scholarship fund, oncology collaboration in Tennessee and Mississippi, and new pharmacy programs for obesity medications. It also highlighted upcoming Q4 2025 results and mentorship initiatives with nursing organizations. These items generally supported network reach and care quality, but short-term price reactions after such news have tended to be modest or negative, making today’s stronger move on the Zynex in-network agreement stand out.

Market Pulse Summary

This announcement highlights Humana’s addition of Zynex as an in‑network provider across multiple pl...

Analysis

This announcement highlights Humana’s addition of Zynex as an in‑network provider across multiple plan types, including Medicare and various Medicaid offerings, effective February 1, 2026. It broadens member access to non‑invasive electrotherapy for pain management within an established national insurer serving nearly 20 million people. Investors may watch for utilization data, member adoption, and any subsequent expansions of similar device‑based partnerships to gauge the long‑term strategic impact.

Key Terms

medicare advantage, medicaid, ppo

3 terms

medicare advantage regulatory

"second-largest provider of Medicare Advantage plans, Humana continues"

Medicare Advantage is a type of health insurance plan offered by private companies that covers services traditionally provided by government-run Medicare. Think of it as a bundled package that combines hospital, doctor, and other medical care into one plan, often with added benefits. For investors, it matters because the popularity and profitability of these plans can influence healthcare companies and the broader health insurance industry.

medicaid regulatory

"Kentucky Medicaid HMO, Illinois Medicaid Plans and Integrated DSNP Plans"

Medicaid is a government-funded health insurance program that provides medical coverage to low-income individuals, families, elderly people and people with disabilities, administered jointly by the federal government and state governments in the United States. For investors, Medicaid matters because changes in eligibility, funding, or payment rules can alter patient volume and the prices hospitals, nursing homes, insurers and medical suppliers receive—similar to how a large customer or contract can shift a company’s revenue outlook.

ppo technical

"Medicare-PPO Plans, POS Plans, Network PFFS Plans, and HMO Plans"

A PPO, or preferred provider organization, is a type of health insurance plan that gives members a network of doctors and hospitals who agree to lower fees, while still allowing patients to see providers outside the network at higher cost. Investors care because PPOs influence how medical services are paid for and used, affecting revenue and margins for insurers, hospitals, drug makers and companies that serve employer health plans—think of it as a merchant discount program that shapes who customers choose and what they pay.

AI-generated analysis. Not financial advice.

ENGLEWOOD, Colo., Feb. 4, 2026 /PRNewswire/ -- Zynex, Inc. (ZYXIQ), an innovative medical device company specializing in non-invasive medical devices for pain management, announced it has for the first time entered into a provider agreement with Humana Inc. (NYSE: HUM), effective February 1, 2026.

"Our non-invasive medical technology improves quality of life for patients with debilitating pain and is a safe and effective alternative for pain management," said Kurt Hudson, Executive Vice President of Marketing. "We are pleased to offer our advanced electrotherapy products, including our NexWave™ device, to in-network Humana members."

Consistently ranked as one of the largest health insurance companies in the United States, and the second-largest provider of Medicare Advantage plans, Humana continues to be a leader among insurers, serving nearly 20 million people across all fifty states. Humana offers products and services through traditional and consumer choice health plans to employer groups, government-sponsored plans, and individuals, as well as primary and workplace care through its medical centers and worksite medical facilities.

"Partnering with a health insurance leader like Humana will expand patient access," added Steven Dyson, Chief Executive Officer. "We thank Humana for trusting our team to serve their members under this agreement and demonstrate how Zynex can provide the highest technology and service standards in the electrotherapy industry with transparency, integrity, and compliance."

Zynex is now participating in health benefits plans offered or administered by Humana, including Medicare-PPO Plans, POS Plans, Network PFFS Plans, and HMO Plans, as well as Kentucky Medicaid HMO, Illinois Medicaid Plans and Integrated DSNP Plans, Indiana PathWays for Aging, Ohio Medicaid Plans, Oklahoma Medicaid, South Carolina Medicaid Plans, Virginia Medicaid Plans, and Michigan Medicaid Plans.

Terms of the agreement were not disclosed.

About Zynex, Inc.
Zynex, founded in 1996, is a pain management device manufacturer and distributor. For additional information, visit: www.zynex.com.

Investor Relations Contact:
Vikram Bajaj, CFO 
E-mail: ir@zynex.com

Media Contact:
Britt Logan DiGiulio
E-mail: media@zynex.com

View original content:https://www.prnewswire.com/news-releases/zynex-announces-new-in-network-provider-status-with-humana-302679009.html

SOURCE Zynex, Inc.

FAQ

What did Zynex announce about its provider status with Humana (HUM) on February 4, 2026?

Zynex entered an in-network provider agreement with Humana effective February 1, 2026, for the first time. According to the company, the deal places Zynex electrotherapy products, including NexWave™, into Humana Medicare-PPO, POS, PFFS, HMO and multiple state Medicaid plans to expand access.

Which Humana plans will accept Zynex devices under the new agreement with Humana (HUM)?

Zynex is participating in Humana Medicare-PPO, POS, Network PFFS and HMO plans under the agreement. According to the company, the participation also covers several state Medicaid plans and Integrated DSNP programs across multiple states.

How might the Humana (HUM) in-network status affect Zynex (ZYXIQ) patients' access to NexWave™?

In-network status should expand patient access to NexWave™ for Humana members across plan types and states. According to the company, Humana membership and included Medicaid plans will allow more members to obtain Zynex electrotherapy products through covered benefits.

Did Zynex disclose financial terms or expected revenue impact from the Humana (HUM) agreement?

No, Zynex did not disclose financial terms or projected revenue effects from the Humana agreement. According to the company, terms of the agreement were not disclosed, so any revenue or timing impact was not provided in the announcement.